Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on BBA AVIATION PLC. We currently have 17 research reports from 2 professional analysts.
|21Mar17 17:29||RNS||Director/PDMR Shareholding|
|20Mar17 16:41||RNS||Annual Financial Report|
|17Mar17 17:16||RNS||Director/PDMR Shareholding|
|08Mar17 14:47||RNS||Holding(s) in Company|
|07Mar17 17:44||RNS||Director/PDMR Shareholding|
|01Mar17 07:00||RNS||Directorate Change|
|01Mar17 07:00||RNS||Final Results|
Frequency of research reports
Research reports on
BBA AVIATION PLC
BBA AVIATION PLC
N+1 Singer - Morning Song 08-11-2016
08 Nov 16
BBA Aviation (BBA LN) Trading in line; Positive bolt-on | EMIS Group (EMIS LN) Shares oversold, fundamentals intact | First Derivatives (FDP LN) Moving into retail analytics | Grafenia (GRA LN) Conditions remain tough | PCI-PAL (PCIP LN) Special dividend confirmed | Trifast (TRI LN) Another strong performance; forecasts upgraded
N+1 Singer - Morning Song 02-08-2016
02 Aug 16
A G Barr (BAG LN) Weak H1 update. We move to Sell | BBA Aviation (BBA LN) Signature outperforming; ERO still challenging | Dialight (DIA LN) Sales decline and high non u/l costs, but strong cash-flow | Elementis (ELM LN) Challenging H1, well positioned for future recovery | Greggs (GRG LN) A successful first half and a reassuring start to H2 | RhythmOne (RTHM LN) Another positive step | SDL (SDL LN) Building confidence in strategy execution | Spirent Communications (SPT LN) Headwinds mask underlying progress | T. Clarke (CTO LN) Solid H1 performance and confident outlook
N+1 Singer - BBA Aviation - Signature outperforming; ERO still challenging
02 Aug 16
We have said previously that FY16 would be a big year for BBA as they integrate the transformational acquisition of Landmark, look to restructure ERO, work to reduce debt levels and also hope that the US economy remains positive enough to help bizjet activity. So far, the integration of Landmark seems to be progressing well, debt is down to 3.2x EBITDA and ERO remains subdued; on balance, we continue to feel that a group intently focused on business and general aviation will ultimately be a more valuable one and the potential sale of ASIG will be the next positive step. We are encouraged by progress and increase our target price to 253p (c.16x FY16 EPS). We move to Buy.
Solid start to a transformational year
06 May 16
As we said in March, this promises to be a big year and, on balance, we continue to feel that a group intently focused on business and general aviation will ultimately be a more valuable one. Trading is in line with expectations and the integration of Landmark is progressing as planned. Landmark integration and debt reduction remain the keys in FY16 and we await further information on the future of ASIG. We remain at Hold.
06 May 16
BBA Aviation (BBA LN) Solid start to a transformational year | Conviviality (CVR LN) Bibendum – A further upward shift in earnings quality and growth | NCC Group (NCC LN) Revenue strong, margins held back by acquisitions | OMG (OMG LN) Contract win highlights Vicon quality | T. Clarke (CTO LN) Full year outlook reiterated, order book at record high | WYG (WYG LN) Capital markets day highlights scale of international opportunity
N+1 Singer - Morning Song 21-03-2017
21 Mar 17
accesso Technology (ACSO LN) Full year results in line, but key trading months still ahead | Augean (AUG LN) Double digit growth in ’16, good start to ‘17 | Earthport (EPO LN) Interims show continued top line strength | Goals Soccer Centres (GOAL LN) Good momentum under new team. It’s now all about delivery | IQE (IQE LN) FY’16 results prompt further upgrades | Microsaic Systems (MSYS LN) Challenges in 2016, strategy remains in place | mporium Group (MPM LN) Funds raised to help execute strategy | RhythmOne (RTHM LN) Dawn of the independents | ScS Group (SCS LN) Strong progress on key growth initiatives albeit comps now toughen | Sinclair Pharma (SPH LN) FY results: EBITDA ahead, Instalift™ gaining pace | Vectura Group (VEC LN) FY (9-month) results
N+1 Singer - Augean - Double digit growth in ’16, good start to ‘17
21 Mar 17
Augean reported another year of double digit growth for 2016, with profits in line with our forecasts. Sales grew by 21% excluding landfill tax, while adjusted PBT grew by 18% to £7.1m before amortisation of acquired intangibles. DPS was increased by 54% to 1.0p, 25% ahead of our estimate. The business units made further strategic progress, with revenues from their top 20 customers increasing from 42% to 43% of the total, of which 88% was under contract or a framework agreement, increasing forward visibility. There has been an encouraging start to 2017 and management is confident of delivering another year of profits growth. The shares trade on undemanding single digit multiples, offering good value.